Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
Severe dystonia as the first manifestation of neuromyelitis optica.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Practical medical applications of quantitative MR relaxometry.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.
No Help from Dalfampridine in MS-Related Optic Neuritis
The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Nrf2 in health and disease: current and future clinical implications.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Antidepressant activity of fingolimod in mice.
Pages
« first
‹ previous
…
191
192
193
194
195
196
197
198
199
…
next ›
last »